Inflammatory bowel diseases (IBD) are chronic disease, with multifactorial etiology, and they are able to develop an inflammatory reaction of immunological nature in the digestive mucosa. The most common manifestations of IBD are ulcerative colitis (UC) and Crohn's disease (CD). To assess the quality of life of their patients is relevant and necessary, considering that the intensity and chronicity of these diseases can bring psychosocial implications on patients' lives. Associated with an increasing prevalence of IBD, these patients have experienced depressive symptoms, anxiety, inhibition and emotional instability which cause significant suffering and may further limit their functional capacity, affecting their quality of life. A cross-sectional study will be developed, in which 53 patients with CD and 53 patients with UC assisted at the outpatient clinic for inflammatory bowel disease of the University Hospital of Botucatu (SP) will be evaluated. A standardized form to obtain demographic and clinical data will be utilized. The Mayo score and the Crohn's disease activity index (CDAI) will be used to evaluate clinical activity of UC and CD, respectively. Depressive symptoms and anxiety will be assessed from the Hospital Anxiety and Depression Scale (HADS). The Medical Outcomes Study 36-item Short Form Health Survey (SF-36) and the Inflammatory Bowel Disease Questionnaire (IBDQ) shall assess the quality of life. Functional capacity and perception of the disease will be evaluated from the Karnofsky scale and the Brief Illness Perception Questionnaire (B-IPQ). It is intended that this work provides information that may contribute to a better understanding on the psychosocial aspects of IBD patients and to the design of interventions to develop a treatment for the disease, improving the quality of life of these patients.Keywords: Inflammatory bowel disease. Quality of life. Functional ability. Perception of the disease. Anxiety. Depression.
News published in Agência FAPESP Newsletter about the scholarship: